BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pennathur A, Farkas A, Krasinskas AM, Ferson PF, Gooding WE, Gibson MK, Schuchert MJ, Landreneau RJ, Luketich JD. Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg. 2009;87:1048-54; discussion 1054-5. [PMID: 19324126 DOI: 10.1016/j.athoracsur.2008.12.060] [Cited by in Crossref: 182] [Cited by in F6Publishing: 159] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Feo CV, Patti MG. Importance of a multidisciplinary approach for the treatment of Barrett's esophagus. Updates Surg 2011;63:5-9. [PMID: 21308492 DOI: 10.1007/s13304-011-0049-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Fristedt R, Gaber A, Hedner C, Nodin B, Uhlén M, Eberhard J, Jirström K. Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma. J Transl Med 2014;12:83. [PMID: 24694107 DOI: 10.1186/1479-5876-12-83] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
3 Luo LN, He LJ, Gao XY, Huang XX, Shan HB, Luo GY, Li Y, Lin SY, Wang GB, Zhang R, Xu GL, Li JJ. Evaluation of preoperative staging for esophageal squamous cell carcinoma. World J Gastroenterol 2016; 22(29): 6683-6689 [PMID: 27547011 DOI: 10.3748/wjg.v22.i29.6683] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
4 Pennathur A, Awais O, Luketich JD. Minimally invasive esophagectomy for Barrett's with high-grade dysplasia and early adenocarcinoma of the esophagus. J Gastrointest Surg 2010;14:948-50. [PMID: 20358407 DOI: 10.1007/s11605-009-1152-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
5 Luo LN, He LJ, Gao XY, Huang XX, Shan HB, Luo GY, Li Y, Lin SY, Wang GB, Zhang R, Xu GL, Li JJ. Endoscopic Ultrasound for Preoperative Esophageal Squamous Cell Carcinoma: a Meta-Analysis. PLoS One. 2016;11:e0158373. [PMID: 27387830 DOI: 10.1371/journal.pone.0158373] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
6 Gan S, Watson DI. New endoscopic and surgical treatment options for early esophageal adenocarcinoma: New treatments early esophageal cancer. Journal of Gastroenterology and Hepatology 2010;25:1478-84. [DOI: 10.1111/j.1440-1746.2010.06421.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
7 Zhu H, Song H, Chen G, Yang X, Liu J, Ge Y, Lu J, Qin Q, Zhang C, Xu L, Di X, Cai J, Ma J, Zhang S, Sun X. eEF2K promotes progression and radioresistance of esophageal squamous cell carcinoma. Radiother Oncol 2017;124:439-47. [PMID: 28431753 DOI: 10.1016/j.radonc.2017.04.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
8 Fujihara S, Morishita A, Ogawa K, Tadokoro T, Chiyo T, Kato K, Kobara H, Mori H, Iwama H, Masaki T. The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo. Oncotarget 2017;8:8536-49. [PMID: 28052030 DOI: 10.18632/oncotarget.14345] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
9 Jin XF, Sun QY, Chai TH, Li SH, Guo YL. Clinical value of multiband mucosectomy for the treatment of squamous intraepithelial neoplasia of the esophagus. J Gastroenterol Hepatol. 2013;28:650-655. [PMID: 23301863 DOI: 10.1111/jgh.12111] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
10 Takeuchi A, Hatta W, Koike T, Saito M, Jin X, Asanuma K, Uno K, Asano N, Imatani A, Fujishima F, Masamune A. A Primary Barrett's Adenocarcinoma with a Squamous Cell Carcinoma Component. Intern Med 2019;58:2467-72. [PMID: 31118396 DOI: 10.2169/internalmedicine.2722-19] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Ashrafi D, Memon B, Memon MA. Management of oesophageal intramucosal carcinoma. BMJ Case Rep 2018;2018:bcr-2018-224893. [PMID: 30217797 DOI: 10.1136/bcr-2018-224893] [Reference Citation Analysis]
12 Newton AD, Predina JD, Xia L, Roses RE, Karakousis GC, Dempsey DT, Williams NN, Kucharczuk JC, Singhal S. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk. Ann Surg Oncol. 2018;25:318-325. [PMID: 29147928 DOI: 10.1245/s10434-017-6238-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
13 Lin J, Chen Z, Wu S, Huang W, Chen F, Huang Z. An NF90/long noncoding RNA-LET/miR-548k feedback amplification loop controls esophageal squamous cell carcinoma progression. J Cancer 2019;10:5139-52. [PMID: 31602267 DOI: 10.7150/jca.30816] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Mallipeddi MK, Onaitis MW. The Contemporary Role of Minimally Invasive Esophagectomy in Esophageal Cancer. Curr Oncol Rep 2014;16. [DOI: 10.1007/s11912-013-0374-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
15 Li H, Zhang S, Guo J, Zhang L. Hepatic Metastasis in Newly Diagnosed Esophageal Cancer: A Population-Based Study. Front Oncol 2021;11:644860. [PMID: 34041021 DOI: 10.3389/fonc.2021.644860] [Reference Citation Analysis]
16 Halder A, Biswas R, Ghosh A, Dastidar AG. Comparative study of concomitant chemoradiation versus concomitant chemoradiation followed by high-dose-rate intraluminal brachytherapy in locally advanced esophageal carcinoma: a single institutional study. J Contemp Brachytherapy 2018;10:225-31. [PMID: 30038642 DOI: 10.5114/jcb.2018.76843] [Reference Citation Analysis]
17 Wei B, Han Q, Xu L, Zhang X, Zhu J, Wan L, Jin Y, Qian Z, Wu J, Gao Y, Zhou J, Chen X. Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma. BMC Cancer 2015;15:331. [PMID: 25925371 DOI: 10.1186/s12885-015-1364-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
18 Hu W, Chen Z, Chen J, Cai D, Chen C, Fang T. LOC441178 Overexpression Inhibits the Proliferation and Migration of Esophageal Carcinoma Cells via Methylation of miR-182. Onco Targets Ther 2020;13:11253-63. [PMID: 33173314 DOI: 10.2147/OTT.S271711] [Reference Citation Analysis]
19 Lu C, Yang L, Chen H, Shan Z. Upregulated long non-coding RNA BC032469 enhances carcinogenesis and metastasis of esophageal squamous cell carcinoma through regulating hTERT expression. Tumor Biol 2016;37:16065-75. [DOI: 10.1007/s13277-016-5428-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
20 Pu Y, Jin P, Liu L, Pu Q, Wu F. Dysosma versipellis Extract Inhibits Esophageal Cancer Progression through the Wnt Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:1221899. [PMID: 34729077 DOI: 10.1155/2021/1221899] [Reference Citation Analysis]
21 Ma DW, Jung DH, Kim JH, Park JJ, Youn YH, Park H. Predicting lymph node metastasis for endoscopic resection of superficial esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2019; 157: 397-402. e1. [PMID: 30143376 DOI: 10.1016/j.jtcvs.2018.07.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
22 Luketich JD, Pennathur A, Awais O, Levy RM, Keeley S, Shende M, Christie NA, Weksler B, Landreneau RJ, Abbas G, Schuchert MJ, Nason KS. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg. 2012;256:95-103. [PMID: 22668811 DOI: 10.1097/sla.0b013e3182590603] [Cited by in Crossref: 469] [Cited by in F6Publishing: 186] [Article Influence: 46.9] [Reference Citation Analysis]
23 D’Journo XB, Thomas PA. Current management of esophageal cancer. J Thorac Dis. 2014;6 Suppl 2:S253-S264. [PMID: 24868443 DOI: 10.3978/j.issn.2072-1439.2014.04.16] [Cited by in F6Publishing: 52] [Reference Citation Analysis]
24 Kumarasinghe MP, Brown I, Raftopoulos S, Bourke MJ, Charlton A, de Boer WB, Eckstein R, Epari K, Gill AJ, Lam AK, Price T, Streutker C, Lauwers GY. Standardised reporting protocol for endoscopic resection for Barrett oesophagus associated neoplasia: expert consensus recommendations. Pathology 2014;46:473-80. [PMID: 25158823 DOI: 10.1097/PAT.0000000000000160] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
25 Perry C, Soomro I, Kaye P, Hardy E, Parsons SL, Ragunath K, Lobo DN, Martin SG, Madhusudan S. Analysis of lymphatic and blood vessel invasion biomarkers in T1 esophagogastric adenocarcinomas for improved patient prognostication: LVI in T1 esophagogastric adenocarcinoma. Dis Esophagus 2015;28:262-8. [DOI: 10.1111/dote.12190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
26 McCarty JC, Parker RK, Vidri RJ, Robinson KA, Lipsitz S, Gangadharan SP, Iyer PG. A retrospective cohort study of endoscopic therapy and esophagectomy for stage 1 esophageal cancer: less is more. Gastrointest Endosc 2020;92:23-30. [PMID: 32276764 DOI: 10.1016/j.gie.2020.01.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
27 Zhang J, Wang R, Liu S, Luketich JD, Chen S, Chen H, Schuchert MJ. Refinement of minimally invasive esophagectomy techniques after 15 years of experience. J Gastrointest Surg. 2012;16:1768-1774. [PMID: 22777054 DOI: 10.1007/s11605-012-1950-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
28 Nesteruk K, Janmaat VT, Liu H, Ten Hagen TLM, Peppelenbosch MP, Fuhler GM. Forced expression of HOXA13 confers oncogenic hallmarks to esophageal keratinocytes. Biochim Biophys Acta Mol Basis Dis 2020;1866:165776. [PMID: 32222541 DOI: 10.1016/j.bbadis.2020.165776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Dermine S, Leconte M, Leblanc S, Dousset B, Terris B, Berger A, Berger A, Rahmi G, Lepilliez V, Plomteux O, Leclercq P, Coriat R, Chaussade S, Prat F, Barret M. Outcomes of esophagectomy after noncurative endoscopic resection of early esophageal cancer. Therap Adv Gastroenterol. 2019;12:1756284819892556. [PMID: 31839807 DOI: 10.1177/1756284819892556] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 Lee HH, Choi MG, Hasan T. Application of photodynamic therapy in gastrointestinal disorders: an outdated or re-emerging technique? Korean J Intern Med 2017;32:1-10. [PMID: 28049283 DOI: 10.3904/kjim.2016.200] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 5.6] [Reference Citation Analysis]
31 Pennathur A, Xi L, Litle VR, Gooding WE, Krasinskas A, Landreneau RJ, Godfrey TE, Luketich JD. Gene expression profiles in esophageal adenocarcinoma predict survival after resection. J Thorac Cardiovasc Surg 2013;145:505-12; discussion 512-3. [PMID: 23321130 DOI: 10.1016/j.jtcvs.2012.10.031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
32 Dubecz A, Kern M, Solymosi N, Schweigert M, Stein HJ. Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer. Ann Thorac Surg. 2015;99:1879-85; discussion 1886. [PMID: 25929888 DOI: 10.1016/j.athoracsur.2015.02.112] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 8.3] [Reference Citation Analysis]
33 Sakai NS, Samia-Aly E, Barbera M, Fitzgerald RC. A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Semin Cancer Biol. 2013;23:512-521. [PMID: 24013023 DOI: 10.1016/j.semcancer.2013.08.005] [Cited by in Crossref: 73] [Cited by in F6Publishing: 78] [Article Influence: 8.1] [Reference Citation Analysis]
34 Stein HJ, Schweigert M, Dubecz A. [Early esophageal cancer: pro surgical resection]. Chirurg 2011;82:495-9. [PMID: 21598061 DOI: 10.1007/s00104-010-2038-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
35 Narsule CK, Montgomery MM, Fernando HC. Evidence-Based Review of the Management of Cancers of the Gastroesophageal Junction. Thoracic Surgery Clinics 2012;22:109-21. [DOI: 10.1016/j.thorsurg.2011.09.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Pennathur A, Godfrey TE, Luketich JD. The Molecular Biologic Basis of Esophageal and Gastric Cancers. Surg Clin North Am 2019;99:403-18. [PMID: 31047032 DOI: 10.1016/j.suc.2019.02.010] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Feber A, Xi L, Pennathur A, Gooding WE, Bandla S, Wu M, Luketich JD, Godfrey TE, Litle VR. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. Ann Thorac Surg. 2011;91:1523-1530. [PMID: 21420070 DOI: 10.1016/j.athoracsur.2011.01.056] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 5.9] [Reference Citation Analysis]
38 Jin G, Yao K, Guo Z, Zhao Z, Liu K, Liu F, Chen H, Gorja DR, Reddy K, Bode AM, Dong Z, Dong Z. APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model. Oncotarget 2017;8:53387-404. [PMID: 28881819 DOI: 10.18632/oncotarget.18508] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
39 Emi M, Hihara J, Hamai Y, Furukawa T, Ibuki Y, Okada M. Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma. Ann Thorac Surg 2017;104:1858-64. [PMID: 29033014 DOI: 10.1016/j.athoracsur.2017.06.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
40 Yang AJ, Choi SH, Byun HK, Kim HJ, Choi J, Lee YC, Lee SK, Park KR, Lee CG. Management of Clinical T1N0M0 Esophageal Cancer. Gut Liver. 2019;13:315-324. [PMID: 30600672 DOI: 10.5009/gnl18254] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
41 Waterhouse DJ, Bano S, Januszewicz W, Stoyanov D, Fitzgerald RC, di Pietro M, Bohndiek SE. First-in-human pilot study of snapshot multispectral endoscopy for early detection of Barrett's-related neoplasia. J Biomed Opt 2021;26. [PMID: 34628734 DOI: 10.1117/1.JBO.26.10.106002] [Reference Citation Analysis]
42 Liu F, Tian T, Xia LL, Ding Y, Cormier RT, He Y. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update. Dis Esophagus 2017;30:1-9. [PMID: 27003597 DOI: 10.1111/dote.12489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
43 Min YW, Lee H, Song BG, Min BH, Kim HK, Choi YS, Lee JH, Hwang NY, Carriere KC, Rhee PL, Kim JJ, Zo JI, Shim YM. Comparison of endoscopic submucosal dissection and surgery for superficial esophageal squamous cell carcinoma: a propensity score-matched analysis. Gastrointest Endosc 2018;88:624-33. [PMID: 29750981 DOI: 10.1016/j.gie.2018.04.2360] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
44 Suh YG, Bayasgalan U, Kim HT, Lee JM, Kim MS, Lee Y, Lee DY, Lee SU, Kim TH, Moon SH. Photon Versus Proton Beam Therapy for T1-3 Squamous Cell Carcinoma of the Thoracic Esophagus Without Lymph Node Metastasis. Front Oncol 2021;11:699172. [PMID: 34235087 DOI: 10.3389/fonc.2021.699172] [Reference Citation Analysis]
45 Nobel TB, Barbetta A, Hsu M, Tan KS, Sihag S, Bains MS, Jones DR, Molena D. Ongoing Challenges with Clinical Assessment of Nodal Status in T1 Esophageal Adenocarcinoma. J Am Coll Surg 2019;229:366-73. [PMID: 31108196 DOI: 10.1016/j.jamcollsurg.2019.04.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
46 Ishihara R, Oyama T, Abe S, Takahashi H, Ono H, Fujisaki J, Kaise M, Goda K, Kawada K, Koike T, Takeuchi M, Matsuda R, Hirasawa D, Yamada M, Kodaira J, Tanaka M, Omae M, Matsui A, Kanesaka T, Takahashi A, Hirooka S, Saito M, Tsuji Y, Maeda Y, Yamashita H, Oda I, Tomita Y, Matsunaga T, Terai S, Ozawa S, Kawano T, Seto Y. Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population. J Gastroenterol. 2017;52:800-808. [PMID: 27757547 DOI: 10.1007/s00535-016-1275-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
47 Nentwich MF, von Loga K, Reeh M, Uzunoglu FG, Marx A, Izbicki JR, Bogoevski D. Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus. J Gastrointest Surg. 2014;18:242-249; discussion 249. [PMID: 24091912 DOI: 10.1007/s11605-013-2367-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
48 Greene CL, Mcfadden PM. The surgeon's perspective on oesophageal disease, and what it means to pathologists. J Clin Pathol 2014;67:913-8. [DOI: 10.1136/jclinpath-2014-202518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
49 Mitchell DP, Yeluri S, Van der Wall H, Falk GL. The real risk of nodal disease in T1 oesophageal adenocarcinoma: A systematic review. Eur Surg 2020;52:110-7. [DOI: 10.1007/s10353-019-00627-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Chen GQ, Tian H, Yue WM, Li L, Li SH, Qi L, Gao C, Si LB, Lu M. NCOA5 low expression correlates with survival in esophageal squamous cell carcinoma. Med Oncol. 2014;31:376. [PMID: 25416054 DOI: 10.1007/s12032-014-0376-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
51 Leggett CL, Prasad GA. High-grade dysplasia and intramucosal adenocarcinoma in Barrett’s esophagus: the role of endoscopic eradication therapy. Curr Opin Gastroenterol. 2012;28:354-361. [PMID: 22450896 DOI: 10.1097/mog.0b013e328352b78a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
52 Wang J, Jiang NQ, Jiang B, Wang ZL, Zhang XY. Mediastinoscopy-assisted oesophagectomy in T1 oesophageal cancer patients with serious comorbidities: a 5-year long-term follow-up. Interact Cardiovasc Thorac Surg 2015;20:477-81. [PMID: 25535180 DOI: 10.1093/icvts/ivu433] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
53 Wang G, Feng B, Niu Y, Wu J, Yang Y, Shen S, Guo Y, Liang J, Guo W, Dong Z. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition. Mol Carcinog 2020;59:1392-408. [PMID: 33079409 DOI: 10.1002/mc.23264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
54 di Pietro M, Canto MI, Fitzgerald RC. Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy. Gastroenterology. 2018;154:421-436. [PMID: 28778650 DOI: 10.1053/j.gastro.2017.07.041] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 12.8] [Reference Citation Analysis]
55 Leggett CL, Lewis JT, Wu TT, Schleck CD, Zinsmeister AR, Dunagan KT, Lutzke LS, Wang KK, Iyer PG. Clinical and histologic determinants of mortality for patients with Barrett’s esophagus-related T1 esophageal adenocarcinoma. Clin Gastroenterol Hepatol. 2015;13:658-664.e1-3. [PMID: 25151255 DOI: 10.1016/j.cgh.2014.08.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
56 Schlottmann F, Patti MG. Current Concepts in Treatment of Barrett's Esophagus With and Without Dysplasia. J Gastrointest Surg 2017;21:1354-60. [PMID: 28353175 DOI: 10.1007/s11605-017-3371-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
57 Wu G, Chen G, Zhou J, Zhu H, Chu J, Zhang F. Liriodenine enhances radiosensitivity in esophageal cancer ECA-109 cells by inducing apoptosis and G2/M arrest. Oncol Lett 2018;16:5020-6. [PMID: 30250568 DOI: 10.3892/ol.2018.9253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
58 Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. The Lancet 2013;381:400-12. [DOI: 10.1016/s0140-6736(12)60643-6] [Cited by in Crossref: 1304] [Cited by in F6Publishing: 852] [Article Influence: 144.9] [Reference Citation Analysis]
59 Wang M, Li Y, Xiao Y, Yang M, Chen J, Jian Y, Chen X, Shi D, Chen X, Ouyang Y, Kong L, Huang X, Bai J, Lin C, Song L. Nicotine-mediated OTUD3 downregulation inhibits VEGF-C mRNA decay to promote lymphatic metastasis of human esophageal cancer. Nat Commun 2021;12:7006. [PMID: 34853315 DOI: 10.1038/s41467-021-27348-8] [Reference Citation Analysis]
60 Xu YW, Peng YH, Ran LQ, Zhai TT, Guo HP, Qiu SQ, Chen HL, Wu ZY, Li EM, Xie JJ. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma. Clin Transl Oncol. 2017;19:898-906. [PMID: 28181176 DOI: 10.1007/s12094-017-1623-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
61 Guo X, Zhao L, Shen Y, Shao Y, Wei W, Liu F. Polymorphism of miRNA and esophageal cancer risk: an updated systemic review and meta-analysis. Onco Targets Ther. 2019;12:3565-3580. [PMID: 31213825 DOI: 10.2147/ott.s193958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
62 Butt J, Kandel G. Barrett esophagus: when to endoscope. Clin Endosc 2014;47:40-6. [PMID: 24570882 DOI: 10.5946/ce.2014.47.1.40] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
63 Zheng D, Ding Y, Ma Q, Zhao L, Guo X, Shen Y, He Y, Wei W, Liu F. Identification of Serum MicroRNAs as Novel Biomarkers in Esophageal Squamous Cell Carcinoma Using Feature Selection Algorithms. Front Oncol. 2018;8:674. [PMID: 30719423 DOI: 10.3389/fonc.2018.00674] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
64 Zhu X, Han S, Wu S, Bai Y, Zhang N, Wei L. Dual role of twist1 in cancer-associated fibroblasts and tumor cells promoted epithelial-mesenchymal transition of esophageal cancer. Exp Cell Res. 2019;375:41-50. [PMID: 30611739 DOI: 10.1016/j.yexcr.2019.01.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
65 Namasivayam V, Wang KK, Prasad GA. Endoscopic mucosal resection in the management of esophageal neoplasia: current status and future directions. Clin Gastroenterol Hepatol. 2010;8:743-54; quiz e96. [PMID: 20541628 DOI: 10.1016/j.cgh.2010.05.030] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
66 Liu X, Wang Z, Zhang G, Zhu Q, Zeng H, Wang T, Gao F, Qi Z, Zhang J, Wang R. High TRAF6 Expression Is Associated With Esophageal Carcinoma Recurrence and Prompts Cancer Cell Invasion. Oncol Res 2017;25:485-93. [PMID: 27697099 DOI: 10.3727/096504016X14749340314441] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
67 Huang B, Chan EG, Pennathur A, Luketich JD, Zhang J. The ideal approach for treatment of cT1N+ and cT2Nany esophageal cancer.: a NCDB analysis. BMC Cancer 2021;21:1334. [PMID: 34911468 DOI: 10.1186/s12885-021-08896-0] [Reference Citation Analysis]
68 Saeed NA, Mellon EA, Meredith KL, Hoffe SE, Shridhar R, Frakes J, Fontaine JP, Pimiento JM, Kothari N, Almhanna K. Adjuvant chemotherapy and outcomes in esophageal carcinoma. J Gastrointest Oncol 2017;8:816-24. [PMID: 29184685 DOI: 10.21037/jgo.2017.07.10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
69 Wang F, Ding X, Wang T, Shan Z, Wang J, Wu S, Chi Y, Zhang Y, Lv Z, Wang L, Fan Q. Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin. PLoS One 2017;12:e0174276. [PMID: 28406985 DOI: 10.1371/journal.pone.0174276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
70 Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P, Trudgill N, Patel P, Kaye PV, Sanders S, O'Donovan M, Bird-Lieberman E, Bhandari P, Jankowski JA, Attwood S, Parsons SL, Loft D, Lagergren J, Moayyedi P, Lyratzopoulos G, de Caestecker J;  British Society of Gastroenterology. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut. 2014;63:7-42. [PMID: 24165758 DOI: 10.1136/gutjnl-2013-305372] [Cited by in Crossref: 733] [Cited by in F6Publishing: 584] [Article Influence: 81.4] [Reference Citation Analysis]
71 Marabotto E, Pellegatta G, Sheijani AD, Ziola S, Zentilin P, De Marzo MG, Giannini EG, Ghisa M, Barberio B, Scarpa M, Angriman I, Fassan M, Savarino V, Savarino E. Prevention Strategies for Esophageal Cancer-An Expert Review. Cancers (Basel) 2021;13:2183. [PMID: 34062788 DOI: 10.3390/cancers13092183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Phillips WA, Lord RV, Nancarrow DJ, Watson DI, Whiteman DC. Barrett's esophagus. J Gastroenterol Hepatol. 2011;26:639-648. [PMID: 21166712 DOI: 10.1111/j.1440-1746.2010.06602.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
73 Wang C, Guan S, Liu F, Chen X, Han L, Wang D, Nesa EU, Wang X, Bao C, Wang N. Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma. Br J Cancer. 2016;114:290-297. [PMID: 26794279 DOI: 10.1038/bjc.2015.463] [Cited by in Crossref: 26] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
74 Chang X, Zhao J, Tian F, Jiang Y, Lu J, Ma J, Zhang X, Jin G, Huang Y, Dong Z, Liu K, Dong Z. Aloe-emodin suppresses esophageal cancer cell TE1 proliferation by inhibiting AKT and ERK phosphorylation. Oncol Lett 2016;12:2232-8. [PMID: 27602169 DOI: 10.3892/ol.2016.4910] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
75 Seerden TC, Larghi A. Staging of early adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc Clin N Am. 2011;21:53-66. [PMID: 21112497 DOI: 10.1016/j.giec.2010.09.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
76 Landau MS, Hastings SM, Foxwell TJ, Luketich JD, Nason KS, Davison JM. Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Mod Pathol 2014;27:1578-89. [PMID: 24762549 DOI: 10.1038/modpathol.2014.66] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
77 Lee L, Ronellenfitsch U, Hofstetter WL, Darling G, Gaiser T, Lippert C, Gilbert S, Seely AJ, Mulder DS, Ferri LE. Predicting Lymph Node Metastases in Early Esophageal Adenocarcinoma Using a Simple Scoring System. Journal of the American College of Surgeons 2013;217:191-9. [DOI: 10.1016/j.jamcollsurg.2013.03.015] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 6.6] [Reference Citation Analysis]
78 Fan M, Lin Y, Pan J, Yan W, Dai L, Shen L, Chen K. Survival after neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis. Thorac Cancer. 2016;7:173-181. [PMID: 27042219 DOI: 10.1111/1759-7714.12299] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
79 Kumarasinghe MP, Armstrong M, Foo J, Raftopoulos SC. The modern management of Barrett's oesophagus and related neoplasia: role of pathology. Histopathology 2021;78:18-38. [PMID: 33382493 DOI: 10.1111/his.14285] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Wen X, Han XR, Fan SH, Zhang ZF, Chen L, Yi G, Wu DM, Lu J, Zheng YL. Down-regulation of XIAP enhances the radiosensitivity of esophageal cancer cells in vivo and in vitro. Biosci Rep. 2017;37. [PMID: 28821565 DOI: 10.1042/bsr20170711] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
81 Leung WD, Chennat J. Comparison of endoscopic and surgical resection of intramucosal carcinoma in Barrett's esophagus. Expert Rev Gastroenterol Hepatol 2011;5:575-8. [PMID: 21910574 DOI: 10.1586/egh.11.65] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
82 Wu Y, Zhou X, Chen Y, Dai J, Yuan Y, Peng G. Endoscopic classification can predict the infiltrative growth patterns of early-stage esophageal cancer: a retrospective study of 133 patients at a single academic tertiary care center. Cancer Invest 2014;32:285-90. [PMID: 24800781 DOI: 10.3109/07357907.2014.911879] [Reference Citation Analysis]
83 Cao B, Yang W, Jin Y, Zhang M, He T, Zhan Q, Herman JG, Zhong G, Guo M. Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling. Journal of Thoracic Oncology 2016;11:1912-26. [DOI: 10.1016/j.jtho.2016.06.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
84 Guo J, Li CQ, Li M, Zuo XL, Yu T, Liu JW, Liu J, Kou GJ, Li YQ. Diagnostic value of probe-based confocal laser endomicroscopy and high-definition virtual chromoendoscopy in early esophageal squamous neoplasia. Gastrointest Endosc. 2015;81:1346-1354. [PMID: 25680899 DOI: 10.1016/j.gie.2014.10.041] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
85 Choi JY, Park YS, Jung HY, Ahn JY, Kim MY, Lee JH, Choi KS, Kim DH, Choi KD, Song HJ, Lee GH, Cho KJ, Kim JH. Feasibility of endoscopic resection in superficial esophageal squamous carcinoma. Gastrointest Endosc. 2011;73:881-889, 889.e1-889.e2. [PMID: 21392755 DOI: 10.1016/j.gie.2010.12.028] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
86 Li F, Ding N, Zhao Y, Yuan L, Mao Y. The current optimal multimodality treatments for oesophageal squamous-cell carcinoma: A systematic review and meta-analysis. Int J Surg. 2018;60:88-100. [PMID: 30389537 DOI: 10.1016/j.ijsu.2018.10.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
87 Liu S, Jiang H, Min L, Ning T, Xu J, Wang T, Wang X, Zhang Q, Cao R, Zhang S, Zhu S. Lysophosphatidic acid mediated PI3K/Akt activation contributed to esophageal squamous cell cancer progression. Carcinogenesis 2021;42:611-20. [PMID: 33367557 DOI: 10.1093/carcin/bgaa143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
88 Schlottmann F, Patti MG, Shaheen NJ. Endoscopic Treatment of High-Grade Dysplasia and Early Esophageal Cancer. World J Surg 2017;41:1705-11. [DOI: 10.1007/s00268-017-3977-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
89 Maehara R, Fujikura K, Takeuchi K, Akita M, Abe-Suzuki S, Karbanová J, Corbeil D, Itoh T, Kakeji Y, Zen Y. SOX2-silenced squamous cell carcinoma: a highly malignant form of esophageal cancer with SOX2 promoter hypermethylation. Mod Pathol 2018;31:83-92. [PMID: 28862264 DOI: 10.1038/modpathol.2017.112] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
90 Qian Z, Wei B, Zhou Y, Wang Q, Wang J, Sun Y, Gao Y, Chen X. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma. BMC Cancer 2019;19:585. [PMID: 31200670 DOI: 10.1186/s12885-019-5818-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
91 Jacobs M, Macefield RC, Blazeby JM, Korfage IJ, van Berge Henegouwen MI, de Haes HCJM, Smets EM, Sprangers MAG. Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer. Qual Life Res 2013;22:1787-803. [DOI: 10.1007/s11136-012-0290-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
92 Ekeke CN, Chan EG, Fabian T, Villa-Sanchez M, Luketich JD. Recommendations for Surveillance and Management of Recurrent Esophageal Cancer Following Endoscopic Therapies. Surg Clin North Am 2021;101:415-26. [PMID: 34048762 DOI: 10.1016/j.suc.2021.03.004] [Reference Citation Analysis]
93 Qumseya BJ, Bartel MJ, Gendy S, Bain P, Qumseya A, Wolfsen H. High rate of over-staging of Barrett's neoplasia with endoscopic ultrasound: Systemic review and meta-analysis. Dig Liver Dis. 2018;50:438-445. [PMID: 29573963 DOI: 10.1016/j.dld.2018.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
94 Batirel S, Yilmaz AM, Sahin A, Perakakis N, Kartal Ozer N, Mantzoros CS. Antitumor and antimetastatic effects of walnut oil in esophageal adenocarcinoma cells. Clinical Nutrition 2018;37:2166-71. [DOI: 10.1016/j.clnu.2017.10.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
95 Kumabe A, Fukada J, Kota R, Koike N, Shiraishi Y, Seki S, Yoshida K, Kitagawa Y, Shigematsu N. Long-term results of concurrent chemoradiotherapy with daily-low-dose continuous infusion of 5-fluorouracil and cisplatin (LDFP) for Stage I-II esophageal carcinoma. Dis Esophagus 2018;31. [PMID: 29228166 DOI: 10.1093/dote/dox138] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
96 Bergeron EJ, Lin J, Chang AC, Orringer MB, Reddy RM. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies. J Thorac Cardiovasc Surg. 2014;147:765-771: Discussion 771-773. [PMID: 24314788 DOI: 10.1016/j.jtcvs.2013.10.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
97 Lee JW, Cho CJ, Kim DH, Ahn JY, Lee JH, Choi KD, Song HJ, Park SR, Lee HJ, Kim YH, Lee GH, Jung HY, Kim SB, Kim JH, Park SI. Long-Term Survival and Tumor Recurrence in Patients with Superficial Esophageal Cancer after Complete Non-Curative Endoscopic Resection: A Single-Center Case Series. Clin Endosc 2018;51:470-7. [PMID: 29860747 DOI: 10.5946/ce.2018.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
98 Zhao X, Chen Q, Cai Y, Chen D, Bei M, Dong H, Xu J. TRA2A Binds With LncRNA MALAT1 To Promote Esophageal Cancer Progression By Regulating EZH2/β-catenin Pathway. J Cancer 2021;12:4883-90. [PMID: 34234858 DOI: 10.7150/jca.55661] [Reference Citation Analysis]
99 Akin EA, Qazi ZN, Osman M, Zeman RK. Clinical impact of FDG PET/CT in alimentary tract malignancies: an updated review. Abdom Radiol (NY) 2020;45:1018-35. [PMID: 32152644 DOI: 10.1007/s00261-020-02447-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
100 Naveed M, Kubiliun N. Endoscopic Treatment of Early-Stage Esophageal Cancer. Curr Oncol Rep. 2018;20:71. [PMID: 30058019 DOI: 10.1007/s11912-018-0713-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
101 Yang S, Li X, Shen W, Hu H, Li C, Han G. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway. J Surg Res 2021;257:267-77. [PMID: 32862055 DOI: 10.1016/j.jss.2020.07.074] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
102 Chen YB, Jia WH. A comprehensive genomic characterization of esophageal squamous cell carcinoma: from prognostic analysis to in vivo assay. Chin J Cancer 2016;35:76. [PMID: 27515178 DOI: 10.1186/s40880-016-0142-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
103 Molena D, Schlottmann F, Boys JA, Blackmon SH, Dickinson KJ, Dunst CM, Hofstetter WL, Lada MJ, Louie BE, Mungo B, Watson TJ, DeMeester SR. Esophagectomy Following Endoscopic Resection of Submucosal Esophageal Cancer: a Highly Curative Procedure Even with Nodal Metastases. J Gastrointest Surg 2017;21:62-7. [PMID: 27561633 DOI: 10.1007/s11605-016-3210-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
104 Zhang LQ, Du XJ, Zhou FY, Chen PN, Wang HL, Sun L, Li XL. Awareness for Endoscopic Screening Among Accompanying Children of Hospitalized Esophageal Cancer Patients in Henan. J Cancer Educ 2020. [PMID: 33137207 DOI: 10.1007/s13187-020-01911-1] [Reference Citation Analysis]
105 Nason KS. Minimal or maximal surgery for esophageal cancer? The Journal of Thoracic and Cardiovascular Surgery 2016;151:633-5. [DOI: 10.1016/j.jtcvs.2015.09.118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
106 Wang C, Li Q, Liu F, Chen X, Liu B, Nesa EU, Guan S, Han L, Tan B, Wang N, Wang X, Song Q, Jia Y, Wang J, Lu M, Cheng Y. Notch2 as a promising prognostic biomarker for oesophageal squamous cell carcinoma. Sci Rep 2016;6:25722. [PMID: 27158037 DOI: 10.1038/srep25722] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
107 Ai D, Zhu H, Ren W, Chen Y, Liu Q, Deng J, Ye J, Fan J, Zhao K. Patterns of distant organ metastases in esophageal cancer: a population-based study. J Thorac Dis. 2017;9:3023-3030. [PMID: 29221275 DOI: 10.21037/jtd.2017.08.72] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
108 Nassani N, Alsheikh M, Carroll B, Nguyen D, Carroll RE. Theranostic Gastrointestinal Endoscopy: Bringing Healing Light to the Lumen. Clin Transl Gastroenterol 2020;11:e00119. [PMID: 32352709 DOI: 10.14309/ctg.0000000000000119] [Reference Citation Analysis]
109 Thomaschewski M, Hummel R, Petrova E, Knief J, Wellner UF, Keck T, Bausch D. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours. World J Gastroenterol 2018; 24(13): 1429-1439 [PMID: 29632424 DOI: 10.3748/wjg.v24.i13.1429] [Reference Citation Analysis]
110 O'Farrell NJ, Reynolds JV, Ravi N, Larkin JO, Malik V, Wilson GF, Muldoon C, O'Toole D. Evolving changes in the management of early oesophageal adenocarcinoma in a tertiary centre. Ir J Med Sci 2013;182:363-9. [PMID: 23242575 DOI: 10.1007/s11845-012-0890-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
111 Yin Q, Liu H, Song Y, Zhou S, Yang G, Wang W, Qie P, Xun X, Liu L. Clinical application and observation of single-port inflatable mediastinoscopy combined with laparoscopy for radical esophagectomy in esophageal squamous cell carcinoma. J Cardiothorac Surg 2020;15:125. [PMID: 32503651 DOI: 10.1186/s13019-020-01168-1] [Reference Citation Analysis]
112 Wang C, Guan S, Chen X, Liu B, Liu F, Han L, Un Nesa E, Song Q, Bao C, Wang X, Cheng Y. Clinical potential of miR-3651 as a novel prognostic biomarker for esophageal squamous cell cancer. Biochem Biophys Res Commun 2015;465:30-4. [PMID: 26210449 DOI: 10.1016/j.bbrc.2015.07.109] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
113 Low DE. Update on staging and surgical treatment options for esophageal cancer. J Gastrointest Surg 2011;15:719-29. [PMID: 21487832 DOI: 10.1007/s11605-011-1515-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
114 Deng W, Jethwa KR, Gonuguntla K, Liao Z, Yoon HH, Murphy MB, Haddock MG, Hallemeier CL, Lin SH. Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal Adenocarcinoma. Adv Radiat Oncol 2020;5:951-8. [PMID: 33083658 DOI: 10.1016/j.adro.2020.03.020] [Reference Citation Analysis]
115 DaVee T, Ajani JA, Lee JH. Is endoscopic ultrasound examination necessary in the management of esophageal cancer? World J Gastroenterol 2017; 23(5): 751-762 [PMID: 28223720 DOI: 10.3748/wjg.v23.i5.751] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
116 Kumarasinghe MP, Bourke MJ, Brown I, Draganov PV, McLeod D, Streutker C, Raftopoulos S, Ushiku T, Lauwers GY. Pathological assessment of endoscopic resections of the gastrointestinal tract: a comprehensive clinicopathologic review. Mod Pathol 2020;33:986-1006. [PMID: 31907377 DOI: 10.1038/s41379-019-0443-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
117 Villaflor VM, Allaix ME, Minsky B, Herbella FA, Patti MG. Multidisciplinary approach for patients with esophageal cancer. World J Gastroenterol 2012; 18(46): 6737-6746 [PMID: 23239911 DOI: 10.3748/wjg.v18.i46.6737] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
118 Thrumurthy SG, Morris JJ, Mughal MM, Ward JB. Discrete-choice preference comparison between patients and doctors for the surgical management of oesophagogastric cancer. Br J Surg 2011;98:1124-31; discussion 1132. [PMID: 21674471 DOI: 10.1002/bjs.7537] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
119 Dunki-Jacobs EM, Martin RC. Endoscopic therapy for Barrett's esophagus: a review of its emerging role in optimal diagnosis and endoluminal therapy. Ann Surg Oncol 2012;19:1575-82. [PMID: 22160480 DOI: 10.1245/s10434-011-2163-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
120 Liu X, Wang Z, Zhang G, Zhu Q, Zeng H, Wang T, Gao F, Qi Z, Zhang J, Wang R. Overexpression of asparaginyl endopeptidase is significant for esophageal carcinoma metastasis and predicts poor patient prognosis. Oncol Lett 2018;15:1229-35. [PMID: 29399177 DOI: 10.3892/ol.2017.7433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
121 Li Q, Gu W, Liu K, Xiao N, Zhang J, Shao L, Li L, Zhang S, Li P. RGD conjugated, Cy5.5 labeled polyamidoamine dendrimers for targeted near-infrared fluorescence imaging of esophageal squamous cell carcinoma. RSC Adv 2016;6:74560-6. [DOI: 10.1039/c6ra12927g] [Cited by in Crossref: 8] [Article Influence: 1.3] [Reference Citation Analysis]
122 Jesinghaus M, Steiger K, Slotta-Huspenina J, Drecoll E, Pfarr N, Meyer P, Konukiewitz B, Bettstetter M, Wieczorek K, Ott K, Feith M, Langer R, Weichert W, Specht K, Boxberg M. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping. Oncotarget 2017;8:46756-68. [PMID: 28657901 DOI: 10.18632/oncotarget.18606] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
123 Yoon HH, Khan M, Shi Q, Cassivi SD, Wu TT, Quevedo JF, Burch PA, Sinicrope FA, Diasio RB. The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection. Mayo Clin Proc. 2010;85:1080-1089. [PMID: 21123634 DOI: 10.4065/mcp.2010.0421] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
124 Peyre CG, Peters JH. Minimally invasive surgery for esophageal cancer. Surg Oncol Clin N Am. 2013;22:15-25, v. [PMID: 23158082 DOI: 10.1016/j.soc.2012.08.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
125 Imai K, Kakushima N, Tanaka M, Takizawa K, Matsubayashi H, Hotta K, Yamaguchi Y, Ono H. Validation of the application of the Japanese curative criteria for superficial adenocarcinoma at the esophagogastric junction treated by endoscopic submucosal dissection: a long-term analysis. Surg Endosc 2013;27:2436-45. [PMID: 23355156 DOI: 10.1007/s00464-012-2755-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
126 Strollo DC, Chan EG, Jaimes Vanegas N, Ocak I, Joubert K, Villa Sanchez M. Innovative and Contemporary Interventional Therapies for Esophageal Diseases. J Thorac Imaging 2019;34:217-35. [PMID: 31219926 DOI: 10.1097/RTI.0000000000000423] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
127 Niu C, Zhao L, Guo X, Shen Y, Shao Y, Liu F. Diagnostic Accuracy of circRNAs in Esophageal Cancer: A Meta-Analysis. Dis Markers 2019;2019:9673129. [PMID: 31534563 DOI: 10.1155/2019/9673129] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
128 Liu Y, Yang H, Fu H, Li M, Feng Z, Peng Z, Liang Z, Wang H. Prognostic impact of examined lymph node count in pT1N0M0 esophageal cancer: A population-based study. Thorac Cancer 2019;10:1636-43. [PMID: 31237106 DOI: 10.1111/1759-7714.13130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
129 Moghadam AR, Mehramiz M, Entezari M, Aboutalebi H, Kohansal F, Dadjoo P, Fiuji H, Nasiri M, Aledavood SA, Anvari K, Simab SA, Khorrami MS, Moradi A, Hassanian SM, Ferns GA, Sales SS, Avan A. A genetic polymorphism in the CYP1B1 gene in patients with squamous cell carcinoma of the esophagus: an Iranian Mashhad cohort study recruited over 10 years. Pharmacogenomics 2018;19:539-46. [DOI: 10.2217/pgs-2018-0197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
130 Barbour AP, Jones M, Brown I, Gotley DC, Martin I, Thomas J, Clouston A, Smithers BM. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol. 2010;17:2494-2502. [PMID: 20349213 DOI: 10.1245/s10434-010-1025-0] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 5.8] [Reference Citation Analysis]
131 Benech N, O'Brien JM, Barret M, Jacques J, Rahmi G, Perrod G, Hervieu V, Jaouen A, Charissoux A, Guillaud O, Legros R, Walter T, Saurin JC, Rivory J, Prat F, Lépilliez V, Ponchon T, Pioche M. Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low-risk tumours are not associated with lymph node metastases. United European Gastroenterol J 2021;9:362-9. [PMID: 32903167 DOI: 10.1177/2050640620958903] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
132 Tanaka T, Matono S, Nagano T, Murata K, Sueyoshi S, Yamana H, Shirouzu K, Fujita H. Photodynamic therapy for large superficial squamous cell carcinoma of the esophagus. Gastrointest Endosc. 2011;73:1-6. [PMID: 21074765 DOI: 10.1016/j.gie.2010.08.049] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
133 Nasr JY, Schoen RE. Prevalence of adenocarcinoma at esophagectomy for Barrett's esophagus with high grade dysplasia. J Gastrointest Oncol 2011;2:34-8. [PMID: 22811825 DOI: 10.3978/j.issn.2078-6891.2010.027] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
134 Luketich JD, Pennathur A, Franchetti Y, Catalano PJ, Swanson S, Sugarbaker DJ, De Hoyos A, Maddaus MA, Nguyen NT, Benson AB. Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study. Ann Surg. 2015;261:702-707. [PMID: 25575253 DOI: 10.1097/sla.0000000000000993] [Cited by in Crossref: 105] [Cited by in F6Publishing: 41] [Article Influence: 15.0] [Reference Citation Analysis]
135 Tanaka T, Matono S, Nagano T, Shirouzu K, Fujita H, Yamana H. Esophagectomy with Extended Lymphadenectomy for Submucosal Esophageal Cancer: Long-Term Outcomes and Prognostic Factors. Ann Surg Oncol 2012;19:750-6. [DOI: 10.1245/s10434-011-2023-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
136 Watson TJ. Esophagectomy for Superficial Esophageal Neoplasia. Gastrointest Endosc Clin N Am 2017;27:531-46. [PMID: 28577773 DOI: 10.1016/j.giec.2017.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
137 Sepesi B, Watson TJ, Zhou D, Polomsky M, Litle VR, Jones CE, Raymond DP, Hu R, Qiu X, Peters JH. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J Am Coll Surg. 2010;210:418-427. [PMID: 20347733 DOI: 10.1016/j.jamcollsurg.2010.01.003] [Cited by in Crossref: 126] [Cited by in F6Publishing: 115] [Article Influence: 10.5] [Reference Citation Analysis]
138 Tian X, Fei Q, Du M, Zhu H, Ye J, Qian L, Lu Z, Zhang W, Wang Y, Peng F, Chen J, Liu B, Li Q, He X, Yin L. miR-130a-3p regulated TGF-β1-induced epithelial-mesenchymal transition depends on SMAD4 in EC-1 cells. Cancer Med 2019;8:1197-208. [PMID: 30741461 DOI: 10.1002/cam4.1981] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
139 Rehmani SS, Liu B, Al-Ayoubi AM, Raad W, Flores RM, Bhora F, Taioli E. Racial Disparity in Utilization of High-Volume Hospitals for Surgical Treatment of Esophageal Cancer. Ann Thorac Surg 2018;106:346-53. [PMID: 29684373 DOI: 10.1016/j.athoracsur.2018.03.042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
140 Tao J, Zhi X, Tian Y, Li Z, Zhu Y, Wang W, Xie K, Tang J, Zhang X, Wang L, Xu Z. CEP55 contributes to human gastric carcinoma by regulating cell proliferation. Tumour Biol. 2014;35:4389-4399. [PMID: 24390615 DOI: 10.1007/s13277-013-1578-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 5.3] [Reference Citation Analysis]
141 Dilworth MP, Nieto T, Stockton JD, Whalley CM, Tee L, James JD, Noble F, Underwood TJ, Hallissey MT, Hejmadi R, Trudgill N, Tucker O, Beggs AD. Whole Genome Methylation Analysis of Nondysplastic Barrett Esophagus that Progresses to Invasive Cancer. Ann Surg 2019;269:479-85. [PMID: 29384778 DOI: 10.1097/SLA.0000000000002658] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
142 Twaddell WS, Wu PC, Verhage RJ, Feith M, Ilson DH, Schuhmacher CP, Luketich JD, Brücher B, Vallböhmer D, Hofstetter WL, Krasna MJ, Kandioler D, Schneider PM, Wijnhoven BP, Sontag SJ. Barrett's esophagus: treatments of adenocarcinomas II. Ann N Y Acad Sci 2011;1232:265-91. [PMID: 21950818 DOI: 10.1111/j.1749-6632.2011.06056.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
143 Wen J, Pang Y, Zhou T, Qi X, Zhao M, Xuan B, Meng X, Guo Y, Liu Q, Liang H, Li Y, Dong H, Wang Y. Essential role of Na+/Ca2+ exchanger 1 in smoking-induced growth and migration of esophageal squamous cell carcinoma. Oncotarget. 2016;7:63816-63828. [PMID: 27588478 DOI: 10.18632/oncotarget.11695] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
144 Jin XF, Gai W, Chai TH, Li L, Guo JQ. Comparison of Endoscopic Resection and Minimally Invasive Esophagectomy in Patients With Early Esophageal Cancer. J Clin Gastroenterol. 2017;51:223-227. [PMID: 27306943 DOI: 10.1097/mcg.0000000000000560] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
145 Ohashi S, Miyamoto S, Kikuchi O, Goto T, Amanuma Y, Muto M. Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma. Gastroenterology. 2015;149:1700-1715. [PMID: 26376349 DOI: 10.1053/j.gastro.2015.08.054] [Cited by in Crossref: 243] [Cited by in F6Publishing: 257] [Article Influence: 34.7] [Reference Citation Analysis]
146 Li T, Xu L, Teng J, Ma Y, Liu W, Wang Y, Chi X, Shao S, Dong Y, Zhan Q, Liu X. GADD45G Interacts with E-cadherin to Suppress the Migration and Invasion of Esophageal Squamous Cell Carcinoma. Dig Dis Sci 2020;65:1032-41. [PMID: 31562612 DOI: 10.1007/s10620-019-05836-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
147 Patti MG, Herbella FA. Role of minimally invasive surgery in the modern treatment of Barrett's esophagus. Gastrointest Endosc Clin N Am 2011;21:135-44. [PMID: 21112503 DOI: 10.1016/j.giec.2010.09.008] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
148 Shi Y, Zhang F, Bai Z, Wang J, Qiu L, Li Y, Meng Y, Valji K, Yang X. Orthotopic Esophageal Cancers: Intraesophageal Hyperthermia-enhanced Direct Chemotherapy in Rats. Radiology 2017;282:103-12. [PMID: 27404050 DOI: 10.1148/radiol.2016152281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
149 Ma K, Cao B, Guo M. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma. Clin Epigenetics 2016;8:43. [PMID: 27110300 DOI: 10.1186/s13148-016-0210-9] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
150 Plum PS, Hölscher AH, Pacheco Godoy K, Schmidt H, Berlth F, Chon S, Alakus H, Bollschweiler E. Prognosis of patients with superficial T1 esophageal cancer who underwent endoscopic resection before esophagectomy—A propensity score-matched comparison. Surg Endosc 2018;32:3972-80. [DOI: 10.1007/s00464-018-6139-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
151 Ye B, Zhang X, Su Y, Hao S, Teng H, Guo X, Yang Y, Sun Y, Mao T, Li Z. The possibility of endoscopic treatment of cN0 submucosal esophageal cancer: results from a surgical cohort. Surg Endosc 2021;35:593-601. [PMID: 32072277 DOI: 10.1007/s00464-020-07420-y] [Reference Citation Analysis]
152 Singhi AD, Arnold CA, Lam-himlin DM, Nikiforova MN, Voltaggio L, Canto MI, Mcgrath KM, Montgomery EA. Targeted next-generation sequencing supports epidermoid metaplasia of the esophagus as a precursor to esophageal squamous neoplasia. Mod Pathol 2017;30:1613-21. [DOI: 10.1038/modpathol.2017.73] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
153 Zhang Y, Zhang Y, Fan H, Shi Y, Zhan C, Wang Q. Study on the role of transient receptor potential C6 channels in esophageal squamous cell carcinoma radiosensitivity. J Thorac Dis 2017;9:3802-9. [PMID: 29268388 DOI: 10.21037/jtd.2017.09.108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
154 Liu AQ, Vogtmann E, Shao DT, Abnet CC, Dou HY, Qin Y, Su Z, Wei WQ, Chen W. A Comparison of Biopsy and Mucosal Swab Specimens for Examining the Microbiota of Upper Gastrointestinal Carcinoma. Cancer Epidemiol Biomarkers Prev 2019;28:2030-7. [PMID: 31519703 DOI: 10.1158/1055-9965.EPI-18-1210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
155 Shimizu H, Arimura Y, Onodera K, Takahashi H, Okahara S, Kodaira J, Oohashi H, Isshiki H, Kawakami K, Yamashita K, Shinomura Y, Hosokawa M. Malignant Potential of Gastrointestinal Cancers Assessed by Structural Equation Modeling. PLoS One 2016;11:e0149327. [PMID: 26889682 DOI: 10.1371/journal.pone.0149327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
156 Goense L, van Rossum PS, Kandioler D, Ruurda JP, Goh KL, Luyer MD, Krasna MJ, van Hillegersberg R. Stage-directed individualized therapy in esophageal cancer. Ann N Y Acad Sci 2016;1381:50-65. [PMID: 27384385 DOI: 10.1111/nyas.13113] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
157 Mehta K, Bianco V, Awais O, Luketich JD, Pennathur A. Minimally invasive staging of esophageal cancer. Ann Cardiothorac Surg. 2017;6:110-118. [PMID: 28446999 DOI: 10.21037/acs.2017.03.18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
158 Liu X, Zhang M, Ying S, Zhang C, Lin R, Zheng J, Zhang G, Tian D, Guo Y, Du C, Chen Y, Chen S, Su X, Ji J, Deng W, Li X, Qiu S, Yan R, Xu Z, Wang Y, Guo Y, Cui J, Zhuang S, Yu H, Zheng Q, Marom M, Sheng S, Zhang G, Hu S, Li R, Su M. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma. Gastroenterology 2017;153:166-77. [PMID: 28365443 DOI: 10.1053/j.gastro.2017.03.033] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 10.0] [Reference Citation Analysis]
159 Saligram S, Chennat J, Hu H, Davison JM, Fasanella KE, McGrath K. Endotherapy for superficial adenocarcinoma of the esophagus: an American experience. Gastrointest Endosc 2013;77:872-6. [PMID: 23472998 DOI: 10.1016/j.gie.2013.01.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
160 Sato H, Inoue H, Kobayashi Y, Maselli R, Santi EG, Hayee B, Igarashi K, Yoshida A, Ikeda H, Onimaru M. Control of severe strictures after circumferential endoscopic submucosal dissection for esophageal carcinoma: oral steroid therapy with balloon dilation or balloon dilation alone. Gastrointest Endosc. 2013;78:250-257. [PMID: 23453294 DOI: 10.1016/j.gie.2013.01.008] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 8.9] [Reference Citation Analysis]
161 Dermine S, Lévi-Strauss T, Abou Ali E, Belle A, Leblanc S, Bibault JE, Barré A, Palmieri LJ, Brezault C, Dhooge M, Terris B, Dohan A, Soyer P, Berger A, Rahmi G, Coriat R, Chaussade S, Barret M. Organ Preservation after Endoscopic Resection of Early Esophageal Cancer with a High Risk of Lymph Node Involvement. Cancers (Basel) 2020;12:E3598. [PMID: 33276430 DOI: 10.3390/cancers12123598] [Reference Citation Analysis]
162 Luo Y, Guda K, Markowitz SD, Chak A, Kaz AM, Grady WM. Esophageal Cancer Biomarkers. In: Srivastava S, editor. Biomarkers in Cancer Screening and Early Detection. Chichester: John Wiley & Sons, Ltd; 2017. pp. 104-17. [DOI: 10.1002/9781118468869.ch9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
163 Evans RPT, Mourad MM, Fisher SG, Bramhall SR. Evolving management of metaplasia and dysplasia in Barrett's epithelium. World J Gastroenterol 2016; 22(47): 10316-10324 [PMID: 28058012 DOI: 10.3748/wjg.v22.i47.10316] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
164 Tirumani H, Rosenthal MH, Tirumani SH, Shinagare AB, Krajewski KM, Ramaiya NH. Esophageal Carcinoma: Current Concepts in the Role of Imaging in Staging and Management. Can Assoc Radiol J 2015;66:130-9. [DOI: 10.1016/j.carj.2014.08.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
165 Shen W, Shen Y, Tan L, Jin C, Xi Y. A nomogram for predicting lymph node metastasis in surgically resected T1 esophageal squamous cell carcinoma. J Thorac Dis. 2018;10:4178-4185. [PMID: 30174862 DOI: 10.21037/jtd.2018.06.51] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
166 Yang J, Luo GY, Liang RB, Zeng TS, Long H, Fu JH, Xu GL, Yang MZ, Li S, Zhang LJ, Lin P, Wang X, Hou X, Yang HX. Efficacy of Endoscopic Ultrasonography for Determining Clinical T Category for Esophageal Squamous Cell Carcinoma: Data From 1434 Surgical Cases. Ann Surg Oncol 2018;25:2075-82. [PMID: 29667114 DOI: 10.1245/s10434-018-6406-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
167 Pratap A, McCarter MD, Watson TJ. Surgical Management of Barrett's-Related Neoplasia. Gastrointest Endosc Clin N Am 2021;31:205-18. [PMID: 33213796 DOI: 10.1016/j.giec.2020.09.003] [Reference Citation Analysis]